source
- FDA shelves fast-track drug review program launched in 2025The U.S. Food and Drug Administration announced it is suspending the fast-track drug review initiative that was introduced in June 2025 under former commissioner Marty Makary. The program, called…
- American Cancer Society recommends routine PSA screening for men 50-69, strengthens guidance for high-risk groupsThe American Cancer Society (ACS) has updated its prostate-cancer screening guidelines, now advising men at average risk aged 50 to 69 to have a PSA blood test every two years. This replaces the 20…